Boonen, S; Adachi, J D; Man, Z; Cummings, S R; Lippuner, K; Törring, O; Gallagher, J C; Farrerons, J; Wang, A; Franchimont, N; San Martin, J; Grauer, A; McClung, M (2011). Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. Journal of clinical endocrinology and metabolism, 96(6), pp. 1727-36. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2010-2784
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
jcem1727.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (304kB) |
The FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis every 6 Months) trial showed denosumab significantly reduced the risk of fractures in postmenopausal women with osteoporosis.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis |
UniBE Contributor: |
Lippuner, Kurt |
ISSN: |
0021-972X |
Publisher: |
Endocrine Society |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:21 |
Last Modified: |
12 Oct 2023 12:39 |
Publisher DOI: |
10.1210/jc.2010-2784 |
PubMed ID: |
21411557 |
Web of Science ID: |
000290810200047 |
BORIS DOI: |
10.48350/6918 |
URI: |
https://boris.unibe.ch/id/eprint/6918 (FactScience: 211990) |
Actions (login required)
 |
Edit item |